Neumora Therapeutics

NMRANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$302.013 M

$1.63 -0.61%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

$236.9M

#935 by earnings

Shares outstanding

182,040,945

Latest filing cover page

P/E ratio

1.3

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#86AgenusAGEN$311.5M
#87Anavex Life SciencesAVXL$309.5M
#88Neumora TherapeuticsNMRA$302.0M
#89SAB BiotherapeuticsSABS$298.2M
#90SurrozenSRZN$297.5M

Where these numbers come from

Share counts and financials for Neumora Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.